Babies born Early Antibody Response to Men B (BEAR Men B)

We are working with Public Health England and a group of UK hospitals to investigate how well the new Men B vaccine, Bexsero®, works in premature babies. This vaccine is given to all babies in the UK to provide protection against one type of bacteria which causes meningitis (inflammation of the lining of the brain) and septicaemia (blood poisoning).

Why are we doing this study?

Currently premature babies receive the same vaccinations as term babies according to the same schedule. We want to investigate whether giving an additional dose of the vaccine gives better protection.

Who can be involved?

We are inviting babies who were born before 35 weeks and who have not yet had their first vaccinations to take part.

What can I do if I’m interested in my baby taking part?

If you would like further information about the study or if you might be interested in your child taking part please contact:

The BEAR MenB Study Team

T: 01865 857679

EMAIL: sheula.barlow@paediatrics.ox.ac.uk or sharon.baugh@paediatrics.ox.ac.uk